Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity A Randomized, Controlled Pilot Study

The objective of this pilot study was to evaluate the effects of exenatide on body mass index (BMI) (primary endpoint) and cardiometabolic risk factors in non-diabetic youth with extreme obesity. Twelve children and adolescents (age 9–16 years old) with extreme obesity (BMI ≥1.2 times the 95(th) per...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelly, Aaron S., Metzig, Andrea M., Rudser, Kyle D., Fitch, Angela K., Fox, Claudia K., Nathan, Brandon M., Deering, Mary, Schwartz, Betsy L., Abuzzahab, M. Jennifer, Gandrud, Laura M., Moran, Antoinette, Billington, Charles J., Schwarzenberg, Sarah Jane
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684414/
https://ncbi.nlm.nih.gov/pubmed/22076596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oby.2011.337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados